Home › astrazeneca
 

Keywords :   


Tag: astrazeneca

Labcyte Announces Collaboration With AstraZeneca To Develop Acoustic Sample Handling For Mass Spectrometry To Advance Drug Discovery

2013-10-02 05:45:13| drugdiscoveryonline News Articles

Labcyte Inc. recently announced a collaboration with AstraZeneca to use acoustic dispensing combined with mass spectrometry to greatly advance drug discovery applications

Tags: develop sample drug advance

 

Merck, AstraZeneca reach deal on cancer treatment

2013-09-11 16:51:46| Biotech - Topix.net

AstraZeneca PLC will take over clinical development of a potential ovarian cancer treatment from Merck & Co.

Tags: treatment deal reach cancer

 
 

Merck and AstraZeneca Enter License Agreement for Investigational Oral WEE1 Kinase Inhibitor Therapy for Cancer

2013-09-11 09:15:00| Merck.com - Research & Development News

Dateline City: WHITEHOUSE STATION, N.J. & LONDON WHITEHOUSE STATION, N.J. & LONDON--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and AstraZeneca (NYSE: AZN) today announced a worldwide licensing agreement for Mercks oral small molecule inhibitor of WEE1 kinase (MK-1775). MK-1775 is currently being evaluated in Phase IIa clinical studies in combination with standard-of-care therapies for the treatment of patients with certain types of ovarian cancer. Language: English Contact: MerckMedia:Caroline Lappetito, (267) 305-7639orInvestor:Carol Ferguson, (908) 423-4465Justin Holko, (908) 423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: for enter agreement license

 

AstraZeneca reverses $285m charge

2013-09-04 13:06:45| Biotech - Topix.net

AstraZeneca has reversed a previous pre-tax impairment charge of $285 million after launching a final-stage Phase III clinical trial for the experimental drug olaparib in ovarian cancer.

Tags: charge reverses astrazeneca 285m

 

AstraZeneca, Pfizer, Novartis Among Suitors for Onyx

2013-07-23 03:20:54| Biotech - Topix.net

The companies, which signed confidentiality agreements and hired advisers, may make first-round bids this week, according to the people, who asked not to be named because the process is private.

Tags: pfizer onyx novartis astrazeneca

 

Sites : [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] next »